ArticlePDF Available

Cardiac index assessment: Validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution

Taylor & Francis
Blood Pressure
Authors:

Abstract and Figures

Introduction: The accuracy of impedance cardiography for cardiac index assessment is matter of debate, with available studies reporting inconsistent results. Our study aimed at evaluating the agreement between measurements of cardiac index provided by a new-generation thoracic electrical bioimpedance device (Hotman System) and an invasive approach based on thermodilution in humans. Methods: Cardiac index was assessed simultaneously with thoracic electrical bioimpedance and conventional thermodilution through comparison of five consecutive measurements in 51 cardiac patients, hospitalized in an intensive care unit (mean± SD age: 60 ± 11 years; 68% males). The agreement between cardiac index values measured by both methods was assessed by the Bland-Altman approach, adjusted for repeated measures. The repeatability coefficient and the intraclass correlation coefficient were used to assess reproducibility of replicates. Results: Average (± SD) cardiac index was 3.05 ± 0.91 l/min/m(2) with Hotman System and 3.14 ± 1.12 l/min/m(2) with thermodilution. The bias of precision was -0.09 ± 0.41. The coefficients of repeatability and intraclass correlation coefficients were high and similar for the two techniques (0.95 l/min/m(2) and 0.91 for Hotman System vs 0.78 l/min/m(2) and 0.90 for thermodilution). Conclusions: Cardiac index values yielded by Hotman system compares favorably with that obtained with thermodilution in cardiac patients.
Content may be subject to copyright.
Correspondence: Gianfranco Parati, Department of Cardiology, S. Luca Hospital, Istituto Auxologico Italiano, Piazzale Brescia 20, 20149 Milano, Italy.
Tel: 39 02 619112949. Fax: 39 02 619112956. E-mail: gianfranco.parati@unimib.it
(Received 26 March 2013 ; accepted 28 May 2013 )
ORIGINAL ARTICLE
Cardiac index assessment: Validation of a new non-invasive very low
current thoracic bioimpedance device by thermodilution
ANDREA FAINI
1
, STEFANO OMBONI
2
, MARIUS TIFREA
3
, SERBAN BUBENEK
3
,
OVIDIU LAZAR
4
& GIANFRANCO PARATI
1
1
Department of Cardiology, IRCCS Ospedale San Luca, Istituto Auxologico Italiano and Department of Health
Sciences, University of Milano Bicocca, Milano, Italy,
2
Italian Institute of Telemedicine, Varese, Italy,
3
Institute of
Emergency for Cardiovascular Diseases Prof. Dr. C.C.Iliescu , Bucharest, Romania;
4
Agrippa Ionescu Military
Emergency Hospital, Balotesti Center of Cardiovascular Disease, Bucharest, Romania
Abstract
Introduction. The accuracy of impedance cardiography for cardiac index assessment is matter of debate, with available stud-
ies reporting inconsistent results. Our study aimed at evaluating the agreement between measurements of cardiac index
provided by a new-generation thoracic electrical bioimpedance device (Hotman System) and an invasive approach based
on thermodilution in humans. Methods. Cardiac index was assessed simultaneously with thoracic electrical bioimpedance
and conventional thermodilution through comparison of fi ve consecutive measurements in 51 cardiac patients, hospitalized
in an intensive care unit (mean SD age: 60 11 years; 68% males). The agreement between cardiac index values measured
by both methods was assessed by the Bland Altman approach, adjusted for repeated measures. The repeatability coeffi cient
and the intraclass correlation coeffi cient were used to assess reproducibility of replicates. Results. Average ( SD) cardiac
index was 3.05 0.91 l/min/m
2
with Hotman System and 3.14 1.12 l/min/m
2
with thermodilution. The bias of precision
was 0.09 0.41. The coeffi cients of repeatability and intraclass correlation coeffi cients were high and similar for the two
techniques (0.95 l/min/m
2
and 0.91 for Hotman System vs 0.78 l/min/m
2
and 0.90 for thermodilution). Conclusions. Cardiac
index values yielded by Hotman system compares favorably with that obtained with thermodilution in cardiac patients.
Key Words: Cardiac output , hemodynamic monitoring , impedance cardiography , thermodilution
Introduction
Critically ill patients often require continuous cardiac
function assessment, and cardiac output monitoring
represents an important diagnostic and prognostic
tool in these conditions (1). The thermodilution
technique is the clinical standard for cardiac output
estimation, but it requires an invasive and costly
procedure, not free from complications (2 5). An
alternative to such an approach might be the use of
impedance cardiography or thoracic electrical bio-
impedance. This technique is based on recording of
changes in the electrical resistance of the chest dur-
ing heartbeat: these variations are then converted to
changes in volume over time and used to derive
stroke volume (6 9). Compared with thermodilu-
tion, impedance cardiography allows hemodynamic
measurements to be carried out more easily and
quickly, and without the risk of infection or other
complications associated with pulmonary artery
catheterization (10). In addition, unlike thermodilu-
tion, the bioimpedance technique enables monitor-
ing of cardiac output in a continuous mode at the
patient s bedside, with a low cost of testing (10).
Since its introduction several years ago, impedance
cardiography has demonstrated its usefulness in
various populations and conditions (10). However, a
number of validation studies suggest a poor correla-
tion between data provided by most impedance
devices and invasive measurements of cardiac outputs
and a wide range of variability in the agreement
between the two methods for the different devices
available on the market (6,9,11 14). This evidence
has questioned the reliability of bioimpedance for
hemodynamic monitoring of critically ill patients,
Blood Pressure, 2013; Early Online: 1–7
ISSN 0803-7051 print/ISSN 1651-1999 online © 2013 Scandinavian Foundation for Cardiovascular Research
DOI: 10.3109 / 08037051.2013.817121
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
2 A. Faini et al.
and has hindered the broad adoption of this technique
as a tool for managing cardiac patients, limiting its
diffusion mainly to physiological studies or peri-
operative applications (1).
Recently, attempts have been made to provide
more reliable non-invasive measurements of hemo-
dynamic parameters through a very low current
thoracic electrical bioimpedance device (Hotman
System, Hemo Sapiens Medical Inc., Sedona, AZ,
USA), making use of a more accurate algorithm for
the calculation of cardiac output (15). Preliminary
evidence exists on the ability of such device to yield
a reproducible non-invasive estimation of cardiac
output in healthy volunteers, but no data on its
clinical accuracy is yet available (16).
The purpose of this study was thus to investigate
the agreement between measurements of cardiac
output simultaneously provided at rest by a reference
invasive measuring methodology (thermodilution)
and by the Hotman non-invasive electrical bioimped-
ance device in patients hospitalized in an intensive
care unit.
Materials and methods
Study design and population
This was a non-randomized, multicenter, national
study, involving two centers located in Romania. The
study was designed to compare the accuracy of the
cardiac output determination by a thoracic electrical
bioimpedance system (Hotman System, Hemo Sapi-
ens Medical Inc., Sedona, Arizona, USA) (15) versus
that obtained with pulmonary artery catheter stan-
dard bolus thermodilution, used as reference gold
standard. The study was performed in 51 cardiac
patients of either gender, aged 18 72 years, hospital-
ized in the intensive care units of Institutul de Urgenta
pentru Boli Cardiovasculare Prof. Dr. C.C. Iliescu
( n 44) and Spitalul Militar de Urgenta Prof. Dr.
Agrippa Ionescu ( n 7), Bucharest, Romania.
Patients were included in the study if there was a
clinical indication for pulmonary artery catheteriza-
tion (patients undergoing cardiac surgery or a cath
lab test), and following initial treatment and stabili-
zation in the critical care unit.
Patients could not be enrolled in the study if
meeting at least one of the following exclusion
criteria: (i) ventricular or dual chamber pacemaker
wearers; (ii) presence of a severe aortic insuffi ciency;
(iii) patients with left to right shunt; (iv) patients with
terminal illness; (v) extremely obese patients (body
mass index 35 kg/m
2
); (vi) patients displaying a
high level of anxiety; (vii) patients undergoing hemo-
dialysis, ultrafi ltration, mechanical ventilation with
continuous positive airway pressure, or life-saving
treatments other than mechanical ventilation, or who
were using a left ventricular assist device (including
intra-aortic balloon pump); (viii) previously enrolled
subjects.
The study was approved by the local ethics
committee of each center. All participants provided
a written informed consent prior to any study
procedure.
Patients were studied in the immediate post-
operative period (all patients had been subjected to
open heart surgery, 33 patients with coronary artery
bypass graft and 18 with valvular problems, aortic
and/or mitral), and cardiac output was determined
at the arrival in the cardiac intensive care unit. Assess-
ment was done in the supine position, simultane-
ously by thermodilution and non-invasive thoracic
electrical bioimpedance: fi ve consecutive determina-
tions at 3-min intervals were scheduled in each sub-
ject. The investigators had to start the recording of
non-invasive hemodynamics each time a bolus was
injected for the thermodilution measurement.
Transpulmonary thermodilution
Thermodilution data were obtained by the fl uid
bolus technique (2,4). A 7.5 French pulmonary
artery catheter (Swan Ganz) was introduced into the
right internal jugular vein and advanced to the pul-
monary artery through the right heart. A 10-ml bolus
of ice-cold 5% dextrose was injected in less than 4 s
in the right atrium. According to the thermodilution
principle, the change in temperature detected in the
blood of the pulmonary artery by a thermistor
positioned at the end of the catheter was used to
calculate cardiac output, using the modifi ed Stewart
Hamilton indicator dilution equation. In order to
improve the accuracy of the determination, each
measurement was based on the average of three
repeated passes, all within 10% of each other, by
excluding the fi rst injection. In total, ve consecutive
measurements within a 3-min interval were per-
formed. Measurements with more than 10% variation
compared with the average of all fi ve measurements
had to be excluded, being considered errors given by
the injection time.
Non-invasive thoracic electrical bioimpedance
Cardiac output was determined also non-invasively
by a novel device based on the thoracic electrical
bioimpedance method (Hotman System) (15). The
system allows a complete non-invasive assessment of
patient s hemodynamic with two important improve-
ments compared with other previous similar devices:
(i) use of a very low current (7 μ A, 300 400-fold
lower than that used by other products, making it
safer for the patient) with a current frequency of
65 kHz, and (ii) use of a new data signal processing
and of an improved mathematical algorithm. The
Hotman system consists of a patient interface for
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
Hemodynamic assessment by thoracic bioimpedance 3
automatic acquisition of blood fl ow and left ventric-
ular parameters through electrodes positioned on
the patient s chest and of a computer equipped with
analysis software. Measured hemodynamics can be
integrated by entering in the software additional
information such as the upper arm blood pressure
and the oxygen saturation level, which are processed
by the software with calculation of additional para-
meters. Measurement of hemodynamic parameters
is pursued through generation of a very low current
circulating between two pairs of solid gel electrodes,
one pair located in the upper part of the laterocervi-
cal region (root of the neck) and the other at the level
of the upper abdomen (midaxillary line at the level
of the xiphoid process): these are the current elec-
trodes (Figure 1). As the alveoli are fi lled with air
(non-conducting medium), the electrical current is
conducted mainly through the thoracic aorta and
the venae cavae. Other four electrodes ( measuring
electrodes ) are placed in close proximity to the cur-
rent electrodes as shown in Figure 1: they record the
electrocardiogram as well as the voltage of the elec-
trical current that crosses the thorax. This current is
proportional to the thoracic impedance, namely to
the tissue resistance when crossed by the electrical
current. As this current is directed by the blood fl ow
through the venae cavae and the thoracic aorta, and
since the blood is the best electrical conductor of the
human body, blood fl ow variations may be translated
in variations of the thoracic impedance.
For the purpose of the validation study, because
of the presence of the pulmonary artery catheter over
the right internal jugular vein, the upper right-sided
sensor of the neck was positioned behind the right
ear lobe and the upper left-sided sensor, just before
the left ear lobe. Before applying the electrodes, the
skin was carefully cleaned with alcohol, to ensure
good adhesion of electrodes and low skin-to-sensor
impedance. The electrodes were then connected
through a patient cable to the bioimpedance system.
Prior to starting hemodynamic measurements, height
and weight values were entered in the system and
body surface area automatically computed, in order
to be used for determination of cardiac indexes
for both non-invasive and invasive methods. The
non-invasive blood fl ow measurement was assessed
concomitantly with the thermodilution measurement
and cardiac index automatically calculated.
Data analysis
The parameter evaluated during the study and
compared between methods was the cardiac index,
defi ned as the ratio between cardiac output and body
surface area and expressed in l/min/m
2
. Body surface
area was calculated by the Du Bois & Du Bois
formula (17).
The study specifi cally aimed at assessing the
accuracy of the non-invasive method and the repeat-
ability of the measurements.
Figure 1. Illustration of the electrode arrays for the thoracic bioimpedance system used in the validation study. Position of current injecting
electrodes and voltage measuring electrodes is reported.
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
4 A. Faini et al.
The agreement between cardiac index values
measured by thermodilution and thoracic bioimped-
ance was assessed by calculating the mean between-
method difference (bias or accuracy), and the
standard deviation (SD) of the difference and the
95% confi dence limits of agreement (precision) as
described by Bland & Altman (18,19). For each
patient and for each single measurement, the differ-
ence between the cardiac index detected by the ther-
modilution method (reference) and by the test device
(thoracic electrical bioimpedance), as well as the
average of the cardiac index value obtained with the
two methods, were computed. Agreement between
the reference and test device was checked by Bland
Altman graphs of reference-test device differences
plotted vs average of the two methods, by consider-
ing the average of fi ve measurements obtained in
each individual (18,19). Percentage error, defi ned as
the ratio between the limits of agreement of the bias
and mean reference cardiac index for the two meth-
ods together, multiplied by 100, was calculated for
interchangeability of the two methods according to
the criterion described by Critchley & Critchley (13).
Acceptance of a new technique should rely on a per-
centage error of up to 30% (13). Kendall s rank
correlation tau ( τ ) test was used to seek a possible
relation between average values and between-method
differences.
Repeatability of replicated measurements for
each method was also assessed by calculating the
within-subject SD of the fi ve replicates and then
the repeatability coeffi cient, defi ned by 1.96 2
multiplied by the within subject SD (18,20). The
repeatability coeffi cient represents the value below
which the absolute difference between two single test
results may be expected to lie with a 95% probability
(20). In addition to the repeatability coeffi cient, the
intraclass correlation coeffi cient was calculated in
order to assess agreement between methods over
repeated measurements (21). The intraclass correla-
tion coeffi cient is measured on a scale of 0 to 1,
where 1 represents perfect reliability with no mea-
surement error and 0 indicates no reliability.
Wherever it was deemed necessary, a correction for
repeated measured was applied, as required by the
local calculation.
Results
A total of 51 cardiac patients were studied, 68% of
which were males. The patients mean age ( SD)
was 60 11 years (range 28 72). Mean cardiac index
( SD) was 3.05 0.91 l/min/m
2
by the thermodilu-
tion method and 3.14 1.12 l/min/m
2
by bioimped-
ance. The correlation between the subject mean
values showed a strong relationship ( τ 0.71;
p 0.0001) between the two methods (Figure 2).
The correlation coeffi cient within subjects was 0.97;
this value showed that an increase in thermodilu-
tion indices within individual was associated with
increase in bioimpedance indices.
The mean thermodilution bioimpedance differ-
ence was 0.09 l/min/m
2
. The relative error of the
bioimpedance method was 26%, namely less than
the 30% maximum acceptable threshold (13). Figure 3,
panel A, shows the Bland Altman graph for
12345678
1
2
3
4
5
6
7
8
CI thermodilution method
[
l/min/m
2
]
CI biompedance method [l/min/m
2
]
Figure 2. Plot of the 255 pairs of cardiac index (CI) estimation derived by bioimpedance ( y -axis) and thermodilution technique ( x -axis).
The continuous line refers to the line of complete agreement (identity).
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
Hemodynamic assessment by thoracic bioimpedance 5
comparison of cardiac index obtained by the two
methods. The limits of agreement using repeated
measurements ( 1.21 and 1.03) were small, sug-
gesting that the test method might be reasonably
accurate. The 95% confi dence interval for the limits
of agreement was also small: 1.41 to 1.01 for the
lower limit of agreement and 0.83 to 1.23 for the
upper limit of agreement. In addition, only one point
(2%), laid outside the 95% limits of agreement, con-
rming that accuracy of the test method was accept-
able for the majority of subjects. The between-method
difference, using the average values for each subjects,
did not systematically vary over the range of mea-
surements as demonstrated by a small and not sta-
tistically signifi cant Kendall s rank correlation tau
( τ 0.17; p 0.089), in spite of the tendency for an
overestimation bias by bioimpedance at higher values
of cardiac index (Figures 2 and 3).
The repeatability coeffi cient for cardiac index
determined by thermodilution was 0.78 l/min/m
2
,
while it was 0.95 l/min/m
2
for the thoracic electrical
bioimpedance method, indicating only a slightly
better internal agreement for the reference method.
The intraclass correlation coeffi cients for fi xed raters
and the assessment for interreader agreement for
random raters were similarly high for both the
thermodilution [0.90 for both (95% confi dence
interval: 0.86, 0.94); p 0.0001] and for the bio-
impedance method [0.91 for both (0.87, 0.94);
p 0.0001], indicating high reliability.
Discussion
In the literature, a fl urry of reports on validation of
different bioimpedance devices vs thermodilution,
the clinical standard for cardiac output determina-
tion (3,4,22), is available. However, so far no
consensus has been reached on the accuracy of
impedance cardiography in the measurement of
cardiac output since in some validation studies the
method was evaluated as highly accurate, whereas in
others more dispersion between the two methods
was found (12,13).
In our paper, we report on a validation study of
a new impedance device against thermodilution by
presenting bias, limits of agreement, percentage error
and repeatability coeffi cients, as currently universally
recommended (13,18,19,23). The Bland Altman
method adjusted for repeated measures was used for
analysis of the validation data because it measures
the extent of deviations from the line of complete
agreement (no bias 0) between the methods
(18,19). This is a much more reliable estimation of
agreement between methods than the correlation
coeffi cient, often used in the past, which measures
how close to a straight line the pairs of measurements
lie, which does not automatically imply that the line
is the one of complete agreement.
We found a good agreement between the cardiac
index measurements determined by non-invasive
and invasive device: the bias between the two meth-
ods was 0.09 l/min/m
2
. The percentage error was
1234567
−2
−1
0
1
2
Average CI thermodilution and biompedance method [L/min/m
2
]
CI difference thermodilution and biompedance method [L/min/m
2
]
−0.09
−1.21 [−1.41;−1.01]
1.03 [0.83;1.23]
Figure 3. Plots of difference in cardiac index (CI) estimation between the reference (thermodilution) and test method (thoracic electrical
bioimpedance system) ( y -axis) vs the average cardiac index value of test and reference method ( x -axis). Data are shown for the 51 cardiac
patients. Dashed lines refer to bias, and upper and lower limits of agreement.
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
6 A. Faini et al.
26%, namely within the 30% limit of agreement:
this indicates that the test method is no less accurate
than the reference method (13), in spite of the ten-
dency towards a small overestimation error by the
bioimpedance device at higher values of cardiac
index. The use of the percentage error strengthens
the study results, since this measure incorporates
not only the error of the method to be tested but
also adjustments for errors in the reference method
itself (13).
In our study, we were also able to obtain repeated
measurements in the same subject. This further
increases the power of our results, but also allowed
us to assess the degree of (short-term) repeatability
of the methodology under test. The coeffi cients of
repeatability were similar for the two methods (0.78
for thermodilution and 0.95 for bioimpedance) and
the intraclass correlation coeffi cients were high (0.90
thermodilution and 0.91 biompedance), both indi-
cating a performance of the non-invasive method
comparable with that of thermodilution.
Although we acknowledge that we were able to
assess only short-term repeatability of cardiac index
by bioimpedance, nevertheless we must emphasize
that limited evidence exists in literature for this
important aspect. Previous evidence suggests that
bioimpedance may have an extremely variable ability
to adequately refl ect cardiac output changes over
time in different situations or during postural changes
(24 27). In addition, it has been shown that the
reproducibility of cardiac index under standardized
conditions is better in the short than in the long term.
Verhoeve and coworkers (28) showed a high degree
of reproducibility of measurements obtained by
means of bioimpedance cardiography during the
same day (at few minutes interval) and after 24 h, in
96 cardiac patients enrolled in a rehabilitation clinic
(28). Intra-day correlation coeffi cient showed a 95%
range of error of 0.92 0.96, while the percentage of
variability in cardiac index from day 1 to day 2 was
6% with a correlation coeffi cient of 0.79 (28). In
another study, performed in 31 consecutive patients
admitted in an intensive care unit, the coeffi cient of
reproducibility for cardiac output obtained with
bioimpedance was very close to that obtained through
thermodilution (0.6 l/min vs 1.0 l/min), but there
was no agreement between the absolute values of
cardiac output (29). Finally, Jewkes and coworkers
(30) evaluated the reproducibility of cardiac output
estimation in resting supine volunteers by a thoracic
electrical bioimpedance cardiograph over a short
time period (30 min) and over several days. The
reproducibility was better on the short term and
worsened on the long term, with an average variation
coeffi cient increasing from 5% to 11%. Unfortu-
nately, in most of the previously referred studies,
an inappropriate or not completely appropriate
analytical approach was employed for assessing
reproducibility.
Limitations of the study
When interpreting the data presented in our study,
some methodological aspects and limitations must
be considered. First, it may be argued that the obser-
vations made are based on a relatively small number
of patients and thus may be of a limited value.
However, the overall number of cardiac index deter-
minations collected in our 51 subjects ( n 255) was
suffi ciently high to empower the study results. Sec-
ond, we assessed reproducibility over a very short
time interval and in standard supine position only.
We cannot exclude, as suggested by the literature for
most devices, that reproducibility of cardiac index
estimation by impedance cardiography with the test
device may worsen when assessed over a longer
observation period or in different postures. Third, we
did not test accuracy in situations or conditions
known to negatively affect reliability of impedance
measurement. We also acknowledge that further stud-
ies are needed to establish the validity of impedance
cardiography by the Hotman device in unconven-
tional situations.
Conclusions
At present, there is much controversy regarding
the utility and safety of the pulmonary artery cath-
eterization for the evaluation of cardiac output.
Non-invasive techniques may represent an attractive
alternative to increase the chance of assessing cardiac
output also in subjects with contraindications to
invasive procedures, but these techniques have not
always met accuracy standards. In our validation
study, we demonstrated that a totally non-invasive
method of cardiac output monitoring by a new-
generation thoracic bioimpedance device may per-
form well as a moderately invasive tool in high risk
cardiac patients. Our results suggest that progress
of hardware and software, including digital signal
processing and new algorithms, may improve the
quality of the results of non-invasive cardiac output
estimation by new devices. However, since accuracy
of measurements by impedance cardiography may be
negatively affected by different conditions and pos-
tures, further studies are required to demonstrate the
reliability of the Hotman device in such situations.
Additional studies are also needed to investigate
more in depth the tendency for an overestimation
bias by the bioimpedance approach at higher values
of cardiac index, observed in our study.
Competing interests
This study was supported by an unrestricted uncon-
ditional grant from the manufacturer of the Hotman
bioimpedance device (Hemo Sapiens Inc. Sedona,
Arizona, USA). The authors have no fi nancial rela-
tionship with any product or manufacturer mentioned
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
Hemodynamic assessment by thoracic bioimpedance 7
in the article. The authors declare that they have no
competing interests.
References
Vincent JL , Rhodes A , Perel A , Martin GS , Della Rocca G , 1.
Vallet B , et al . Clinical review: Update on hemodynamic
monitoring A consensus of 16 . Crit Care. 2011 ; 15 : 229 .
Mathews L , Singh RK . Swan Ganz catheter in hemodynamic 2.
monitoring . J Anaesth Clin Pharmacol. 2006 ; 22 : 335 345 .
Mathews L , Singh RK . Cardiac output monitoring . Ann Card 3.
Anaesth. 2008 ; 11 : 56 68 .
Reuter DA , Huang C
, Edrich T , Shernan SK , Eltzschig HK . 4.
Cardiac output monitoring using indicator dilution tech-
niques: Basics, limits, and perspectives . Anesth Analg. 2010 ;
110 : 799 811 .
Alhashemi JA , Cecconi M , Hofer CK . Cardiac output moni-5.
toring: An integrative perspective . Crit Care. 2011 ; 15 : 214 .
Woltjer HH , Bogaard HJ , de Vries PM . The technique of 6.
impedance cardiography . Eur Heart J. 1997 ; 18 : 1396 1403 .
Osypka MJ , Bernstein DP . Electrophysiologic principles and 7.
theory of stroke volume determination by thoracic electrical
bioimpedance . AACN Clin Issues.
1999 ; 10 : 385 399 .
Strobeck JE , Silver MA . Beyond the four quadrants: The 8.
critical and emerging role of impedance cardiography in heart
failure . Congest Heart Fail. 2004 ; 10 Suppl 2 : 1 6 .
Tang WH , Tong W . Measuring impedance in congestive heart 9.
failure: Current options and clinical applications . Am Heart J.
2009 ; 157 : 402 411 .
Sodolski T , Kutarski A . Impedance cardiography: A valuable 10.
method of evaluating haemodynamic parameters . Cardiol J.
2007 ; 14 : 115 126 .
Fuller HD . The validity of cardiac output measurement by 11.
thoracic impedance: A meta-analysis . Clin Invest Med. 1992 ;
15 : 103 112 .
Raaijmakers E , Faes TJ , Scholten RJ , Goovaerts HG , 12.
Heethaar RM . A meta-analysis of three decades of validating
thoracic impedance cardiography . Crit Care Med. 1999 ; 27 :
1203 1213 .
Critchley LA , Critchley JA . A meta-analysis of studies using 13.
bias and precision statistics to compare cardiac output meas-
urement techniques . J Clin Monit Comput. 1999 ; 15 : 85 91 .
Wang DJ , Gottlieb SS . Impedance cardiography: More ques-14.
tions than answers . Curr Cardiol Rep. 2006 ; 8 : 180 186 .
Badila E , T î rziu C , Iorgulescu CN
, Stefuriac M , Bartos D , 15.
Dorobantu M . The role of thoracic electrical bioimpedance
in the control of high blood pressure . Revista rom â na de
cardiologie. 2006 ; 21 : 13 20 .
Mimoun L , Hering D , Boutouyrie P , Kucharska W , Laurent S , 16.
Narkiewicz K . Reproducibility of non-invasive cardiac index
measurement with impedancemetry in hypertensives and
healthy controls [abstract] . J Hypertens. 2009 ; 27 Suppl 4 : S370 .
Du Bois D , Du Bois EF . A formula to estimate the approxi-17.
mate surface area if height and weight be known. 1916 .
Nutrition. 1989 ;5: 303 311 .
Altman DG ,
Bland JM . Measurement in medicine: The 18.
analysis of method comparison studies . Statistician. 1983 ; 32 :
307 317 .
Bland JM , Altman DG . Statistical methods for assessing 19.
agreement between two methods of clinical measurement .
Lancet. 1986 ; 1 : 307 310 .
British Standards Institution . Precision of test methods, 20.
part 1: Guide for the determination of repeatability and
reproducibility for a standard test method . BS 5497, Part 1.
London: BSI; 1979 .
Koch GG . Intraclass correlation coeffi cient. In Kotz S, 21.
Johnson NL, editors. Encyclopedia of statistical sciences.
4. New York: John Wiley & Sons; 1982 . p 213 217 .
Stetz CW , Miller RG , Kelly GE , Raffi n TA . Reliability of the 22.
thermodilution method in the determination of cardiac
output in clinical practice . Am Rev Respir Dis.
1982 ; 126 :
1001 1004 .
Cecconi M , Rhodes A , Poloniecki J , Della Rocca G , 23.
Grounds RM . Bench-to-bedside review: The importance of
the precision of the reference technique in method compari-
son studies With specifi c reference to the measurement of
cardiac output . Crit Care. 2009 ; 13 : 201 .
Hartleb M , Rudzki K , Waluga M , Janusz M , Karpel E . 24.
Usefulness of thoracic electrical bioimpedance in detection of
ejection fraction changes . J Physiol Pharmacol. 2000 ; 51 :
151 159 .
Heringlake M , Handke U , Hanke T , Eberhardt F , 25.
Schumacher J , Gehring H , Heinze H . Lack of agreement
between thermodilution and electrical velocimetry cardiac
output measurements . Intensive Care Med. 2007 ; 33 :
2168 2172 .
Tomsin K , Mesens T , Molenberghs G , Gyselaers W . Diurnal 26.
and position-induced variability of impedance cardiography
measurements in healthy subjects . Clin Physiol Funct
Imaging. 2011 ; 31 : 145 150 .
Reisner AT , Xu D , Ryan KL , Convertino VA , Rickards CA , 27.
Mukkamala R . Monitoring non-invasive cardiac output and
stroke volume during experimental human hypovolaemia and
resuscitation . Br J Anaesth. 2011 ; 106 : 23 30 .
Verhoeve PE , Cadwell CA , Tsadok S . Reproducibility of non 28.
invasive bioimpedance measurements of cardiac function
[abstract] . J Card Fail. 1998 ; 4(suppl.) : S34
Ng HW , Coleman N , Walley TJ , Mostafa SM , Breckenridge AM . 29.
Reproducibility and comparison of cardiac output measure-
ment by transthoracic bioimpedance and thermodilution
methods in critically ill patients . Clin Intensive Care. 1993 ; 4 :
217 221 .
Jewkes C , Sear JW , Verhoeff F , Sanders DJ , Fo ë x P . Non-30.
invasive measurement of cardiac output by thoracic electrical
bioimpedance: A study of reproducibility and comparison
with thermodilution . Br J Anaesth. 1991 ; 67 : 788
794 .
Blood Press Downloaded from informahealthcare.com by 123.127.93.18 on 08/09/13
For personal use only.
... However, validation of non-invasive monitoring devices and impedance cardiography against TD has mainly been performed in surgical patients and children with congenital heart disease [5][6][7][8][9][10][11][12][13][14][15][16][17][18], and only one previous study specifically validated non-invasive pulse contour analysis against TD measurements in patients with systolic HF [19]. Diagnostic benefit from non-invasive measurement would be particularly high in the latter population as assessment of CO is therapeutically decisive when it comes to mechanical circulatory support (e.g. ...
... However, there is reason to assume that in patients with systolic HF the validity of TBI for assessment of CO could be limited by systolic HF itself since forward and backward failure may hamper reliable measurement of both blood pressure and thoracic impedance [1,21]. Indeed, previous validation studies in non-HF patients yielded inconclusive results with some of them deeming the validity of TBI acceptable and others deeming it unacceptable [5][6][7][8][9][10][11][12][13][14][15][16][17][18]20]. ...
... Therefore, the use of TBI-based CO and SV assessment cannot be recommended in patients with systolic HF, in particular. This finding corresponds to previous studies that evaluated other techniques or devices for a non-invasive estimation of CO and SV. Figure 5 and online resource 3 summarize these previous validation studies using right heart catheterization and TD as a reference [5,[7][8][9][13][14][15][16][17][18]. ...
Article
Full-text available
Cardiac output (CO) is a key parameter in diagnostics and therapy of heart failure (HF). The thermodilution method (TD) as gold standard for CO determination is an invasive procedure with corresponding risks. As an alternative, thoracic bioimpedance (TBI) has gained popularity for CO estimation as it is non-invasive. However, systolic heart failure (HF) itself might worsen its validity. The present study validated TBI against TD. In patients with and without systolic HF (LVEF ≤ 50% or > 50% and NT-pro-BNP < 125 pg/ml, respectively) right heart catheterization including TD was performed. TBI (Task Force Monitor©, CNSystems, Graz, Austria) was conducted semi-simultaneously. 14 patients with and 17 patients without systolic HF were prospectively enrolled in this study. In all participants, TBI was obtainable. Bland-Altman analysis indicated a mean bias of 0.3 L/min (limits of agreement ± 2.0 L/min, percentage error or PE 43.3%) for CO and a bias of -7.3 ml (limits of agreement ± 34 ml) for cardiac stroke volume (SV). PE was markedly higher in patients with compared to patients without systolic HF (54% vs. 35% for CO). Underlying systolic HF substantially decreases the validity of TBI for estimation of CO and SV. In patients with systolic HF, TBI clearly lacks diagnostic accuracy and cannot be recommended for point-of-care decision making. Depending on the definition of an acceptable PE, TBI may be considered sufficient when systolic HF is absent. Trial registration number: DRKS00018964 (German Clinical Trial Register, retrospectively registered)
... The other 4 electrodes were placed in the costal area bilaterally, which recorded the electrocardiogram and the voltage of the electrical current that crossed the thorax. 7 The examination lasted a total of 60 minutes. We recorded changes in variables for a minimum of 30 minutes in the supine position and 30 minutes in the prone position. ...
Article
Objective: To study the respiratory patterns and the hemodynamic variations related to postural changes in inpatients with coronavirus disease (COVID-19). Methods: This report is a prospective study in a cohort of inpatients admitted with COVID-19. We recruited 10 patients admitted to the hospital with moderate or severe COVID-19 who showed improvement in oxygen saturation with prone positioning. We performed cardiorespiratory polygraphy and hemodynamic evaluations by thoracic electrical bioimpedance. Results: We observed a median minimum oxygen saturation of 85.00% (IQR: 7.00) in the supine position versus 91.00% (IQR: 8.00) (P = 0.173) in the prone position. The airflow restriction in the supine position was 2.70% (IQR: 6.55) versus 1.55% (IQR: 2.80) (P = 0.383) in the prone position. A total of 36.4% of patients were classified as having a normo-hemodynamic state in the supine position, whereas 54.5% were classified in this group in the prone position (P = 0.668). A decrease in vascular resistance was observed in the prone position (18.2% of vasoconstriction) compared to the supine position (36.4% of vasoconstriction) (P = 0.871). Conclusion: This brief report describes the effects of prone positioning on respiratory and hemodynamic variables in 10 patients with moderate or severe COVID-19.
... In order to prove the accuracy and the reliability of ICG in the determination of these hemodynamic parameters, this technique has been widely compared to different invasive and non-invasive methods such as echocardiography [66][67][68][69], thermodilution [70][71][72][73], oesophageal doppler [74][75][76], and magnetic resonance imaging [77][78][79]. Noted that the validation of this technique has been performed on many clinical cases by using different ICG device marks. ...
Article
Over the last decade, Computer-Aided Diagnosis (CAD) systems have been provided significant research focus by researchers. CAD systems have been developed in order to minimise visual errors, to compensate manual interpretation, and to help medical staff to take decisions swiftly. These systems have been considered as powerful tools for a reliable, automatic, and low-cost monitoring and diagnosis. CAD systems are based on analysis and classification of several physiological signals for detecting and assessing different diseases related to the corresponding organ. The implementation of these systems requires the application of several advanced signal processing techniques. Specifically, in cardiology, CAD systems have achieved promising results in providing an accurate and rapid detection of cardiovascular diseases (CVDs). Particularly, the number of works on signal processing field for impedance cardiography (ICG) signals starts to grow slowly in recent years. This paper presents a review study of signal processing techniques applied to the ICG signal for the denoising, the analysis, the classification and the characterisation purposes. This review is intended to provide researchers with a broad overview of the currently used signal processing techniques for ICG signal analysis, as well as to improve future research by applying other recent advanced methods.
... In short, of 65 patients with apparent treatment-resistant hypertension who were referred for RDN, 45 patients were excluded after a thorough investigation, either due to secondary causes or after obtaining a normalised daytime ABPM following witnessed intake of drugs as previously described by us and detailed in the Online Supplement [14]. Thus, 20 patients were randomised to either RDN or drug adjustment assisted by hemodynamic assessments using the HOTMAN system (Hemo Sapiens Inc. Sedona, AZ), described in detail by others [15]. Treatment was at all times in accordance with the latest guidelines of the European Society of Hypertension/European Society of Cardiology Guidelines on arterial hypertension [16][17][18]. ...
Article
Purpose: The blood pressure (BP) lowering effect of renal sympathetic denervation (RDN) in treatment-resistant hypertension shows variation amongst the existing randomised studies. The long-term efficacy and safety of RDN require further investigation. For the first time, we report BP changes and safety up to 7 years after RDN, compared to drug adjustment in the randomised Oslo RDN study. Materials and methods: Patients with treatment-resistant hypertension, defined as daytime systolic ambulatory BP ≥135 mmHg after witnessed intake of ≥3 antihypertensive drugs including a diuretic, were randomised to either RDN (n = 9) or drug adjustment (n = 10). The initial primary endpoint was the change in office BP after 6 months. The RDN group had their drugs adjusted after 1 year using the same principles as the Drug Adjustment group. Both groups returned for long-term follow-up after 3 and 7 years. Results: The decrease in office BP and ambulatory BP (ABPM) after 6 months did not persist, but gradually increased in both groups. From 6 months to 7 years follow-up, mean daytime systolic ABPM increased from 142 ± 10 to 145 ± 15 mmHg in the RDN group, and from 133 ± 11 to 137 ± 13 mmHg in the Drug Adjustment group, with the difference between them decreasing. In a mixed factor model, a significantly different variance was found between the groups in daytime systolic ABPM (p = .04) and diastolic ABPM (p = .01) as well as office diastolic BP (p<.01), but not in office systolic BP (p = .18). At long-term follow-up we unveiled no anatomical- or functional renal impairment in either group. Conclusions: BP changes up to 7 years show a tendency towards a smaller difference in BPs between the RDN and drug adjustment patients. Our data support RDN as a safe procedure, but it remains non-superior to intensive drug adjustment 7 years after the intervention.
... We want to identify the hemodynamic profi le of elderly hypertensive patients and the relationship with the antihypertensive medication for a modern management of hypertension treatment. Th e Th oracic Electric Bioimpedance (TEB) is a noninvasive technology developed by HemoSapiens 15,16 , who allows standard evaluation of hemodynamic modulators and has demonstrated its usefulness and replicability in various populations 17,18 . ...
... WatchBP O3 (Microlife Health Management Ltd, Cambridge, United Kingdom) was used for all BP measurements. Thoracic impedance cardiography measurements were performed with the validated non-invasive HOTMAN System (Hemo Sapiens Inc., Sedona, AZ, USA) [16][17][18], the supplemental online material provide details on the procedure. The HOTMAN System also provided us with an algorithm that calculated deviations in systemic vascular resistance, volume load and cardiac inotropy, i.e. the patients' hemodynamic status [13]. ...
Article
Purpose Renal sympathetic denervation (RDN) is again gaining interest as recent well-designed trials have demonstrated reduced ambulatory blood pressure (BP) after RDN. However, the hemodynamic mechanisms have not been elucidated. We aimed for the first time to investigate the effect of RDN on the “Hallmark of Hypertension” namely increased systemic vascular resistance index (SVRI). Materials and methods We investigated SVRI change in patients with true treatment-resistant hypertension randomised to RDN (n = 9) or drug adjusted control (n = 9). Treatment-resistant hypertension was defined as office systolic BP ≥ 140 mmHg despite ≥ 3 antihypertensive drugs including a diuretic. True treatment-resistant hypertension was confirmed prior to inclusion with ambulatory daytime systolic BP ≥ 135 mmHg immediately after witnessed intake of antihypertensive drugs. Hemodynamic variables were recorded with thoracic impedance cardiography at baseline and at three and six months follow-up after RDN. This non-invasive method also guided further tailoring of drug treatment in the control group aiming to normalise hemodynamic variables and BP. Results From three to six months follow-up after RDN, SVRI decreased with a median of −611 dyn*s*m²/cm⁵ [IQR −949 to −267] (p < 0.01), while supine mean BP decreased with a median of −11 mmHg [IQR −21 to −3] (p = 0.02). In the same period, SVRI in the control group was reduced with −674 dyn*s*m²/cm⁵ [IQR −1,309 to −340] (p < 0.01), while supine mean BP decreased with −15 mmHg [IQR −29 to −6] (p = 0.01). Thus, hemodynamic variables and BP in the two groups normalised in parallel. Conclusion Our data suggest that in patients with true treatment-resistant hypertension, renal sympathetic denervation lowers BP by reducing systemic vascular resistance of similar size as in the control group with careful individual selection of antihypertensive drugs and dose titration.
... Impedance cardiography (ICG) is a simple, non-invasive, and cost effective technique for assessing stroke volume (SV), cardiac output (CO) and others hemodynamic parameters [1]. In order to establish its validity, ICG has been widely compared to several methods which measure stroke volume and cardiac output [3], such as echocardiography [4,5], thermodilution [6,7], and the Fick method [8]. Impedance cardiography has been used for many clinical purposes. ...
Article
Impedance cardiography (ICG) is a simple, non-invasive and cost effective tool for monitoring hemodynamic parameters. It has been successfully used to diagnose several cardiovascular diseases, like the heart failure and myocardial infarction. In particular, valvular heart disease (VHD) is characterized by the affection of one or more heart valves: mitral, aortic, tricuspid or pulmonary valves and it is usually diagnosed using the Doppler echocardiography. However, this technique is rather expensive, requires qualified expertise, discontinuous, and often not necessary to make just a simple diagnosis. In this paper, a new computer aided diagnosis system is proposed to detect VHD using the ICG signals. Six types of ICG heartbeats are analyzed and classified: normal heartbeats (N), mitral insufficiency heartbeats (MI), aortic insufficiency heartbeats (AI), mitral stenosis heartbeats (MS), aortic stenosis heartbeats (AS), and pulmonary stenosis heartbeats (PS). The proposed methodology is validated on 120 ICG recordings. Firstly, ICG signal is denoised using the Daubechies wavelet family with order eight (db8). Then, these signals are segmented into several heartbeats and, later, subjected to the linear prediction LP and discrete wavelet transform DWT approaches to extract temporal and time–frequency features, respectively. In order to reduce the number of features and select the most relevant ones among them, the Student's t-test is applied. Therefore, a total of 16 features are selected (3 temporal features and 13 time–frequency features). For the classification step, the support vector machine SVM and k-nearest neighbors KNN classifiers are used. Different combinations between extracted features and classifiers are proposed. Hence, experimental results showed that the combination between temporal features, time–frequency features and SVM classifier achieved the highest classification performance in classifying the N, MI, MS, AI, AS and PS heartbeats with 98.94% of overall accuracy.
Article
Background: We recently showed in a proof-of-concept study that treating individuals with primary aldosteronism with the mTOR-inhibitor everolimus decreases home blood pressure and renin suppression overall, and markedly reduces aldosterone levels in a subset of individuals. Based on these findings, the question arose whether the effects of everolimus were also mediated via aldosterone-independent mechanisms. Here, we undertook an exploratory, secondary analysis of above-mentioned study to comprehensively investigate how everolimus impacted the hemodynamic status of the study participants, which in turn could elucidate these mechanisms. Methods: Hemodynamic parameters were measured in study participants with primary aldosteronism at baseline, after treatment with everolimus 0.75 mg orally twice daily for 2 weeks and after a 2-week wash-out. Of the 14 participants, 10 participants had complete data sets for peripheral and central blood pressure, heart rate and pulse wave velocity, and 7 participants had complete data sets for cardiac index, inotropic state index, left stroke work index and stroke systemic vascular resistance index that could be analyzed. Parameters were acquired by brachial oscillometry (Mobil-o-graph PWA) and thoracic electrical bioimpedance (HOTMAN® System). Results: After treatment with everolimus, peripheral (p = 0.049) and central (p = 0.037) diastolic blood pressure, as well as hypervolemia (p = 0.008) were significantly decreased. Likewise, peripheral (p = 0.073) and central systolic blood pressure (p = 0.166) trended downwards. Conclusions: Everolimus lowers central and peripheral blood pressure in individuals with primary aldosteronism, possibly by decreasing primary aldosteronism-induced hypervolemia and preload.
Article
Full-text available
Objective: Noninvasive thoracic bioimpedance by the HOTMAN System estimates hemodynamic modulators and expresses them as hemodynamic profiles. Aims of this analysis were to describe hemodynamic profiles among treatment-naive hypertensive patients compared with normotensive controls and to investigate whether a hemodynamic-guided choice of therapy improves blood pressure (BP) control within 4 weeks. Method: This exploratory post hoc analysis used data of a randomized parallel-group trial including 80 outpatients with newly diagnosed arterial hypertension (AHT), randomized to four antihypertensive first-line monotherapies, and 20 age-matched and sex-matched normotensive controls. Hemodynamic profiles were measured at baseline and after four weeks of treatment. On the basis of the hemodynamic profiles, the most appropriate pharmacological treatment was determined retrospectively and patients were categorised to have received concordant (ConTG) or discordant treatment (DisTG). Results: In the hypertensive group, hypervolemia with vasoconstriction was the predominant hemodynamic profile in 48% of patients and hypervolemia without vasoconstriction in 45%, compared with 15 and 50%, respectively, in the control group. After 4 weeks of treatment, the mean (±SD) 24-h BP was 129.9 (±11.0)/81.5 (±8.0) mmHg in the DisTG vs. 133.9 (±12.3)/84.0 (±9.1) mmHg in the ConTG (P = 0.158/0.222). The mean 24-h BP reductions were -9.7 (±10.1)/-5.0 (±6.2) mmHg in the DisTG and -12.4 (±14.8)/-6.9(±6.9) mmHg in the ConTG (P = 0.353/0.223). After 4 weeks of treatment, the BP control rate was 53.7% (43/80) among all, 55.7% (29/52) in the DisTG and 48% (12/25) in the ConTG (P = 0.628). Conclusion: Our findings do not support the hypothesis that personalized treatment initiation based on hemodynamic profiles improves BP control in newly diagnosed hypertensive outpatients.
Article
Full-text available
Hemodynamic monitoring plays a fundamental role in the management of acutely ill patients. With increased concerns about the use of invasive techniques, notably the pulmonary artery catheter, to measure cardiac output, recent years have seen an influx of new, less-invasive means of measuring hemodynamic variables, leaving the clinician somewhat bewildered as to which technique, if any, is best and which he/she should use. In this consensus paper, we try to provide some clarification, offering an objective review of the available monitoring systems, including their specific advantages and limitations, and highlighting some key principles underlying hemodynamic monitoring in critically ill patients.
Article
Swan, Ganz and colleagues introduced pulmonary artery catheterization for hemodynamic monitoring into clinical practice in 1970. The pulmonary artery catheter, also known as Swan Ganz catheter, allowed accurate measurement of important cardiovascular physiological variables at the bedside and became increasingly popular as they were used in critically ill patients. Proper use of Swan Ganz catheter discloses a wide range of pertinent cardiovascular data that cannot be predicted from standard clinical signs and symptoms. The present article deals with the physiologic basis for pulmonary artery pressure monitoring, method of catheterization, clinical applications and complications associated with Swan Ganz catheter use. In addition to pressure monitoring the basis of intermittent cardiac output monitoring using Swan Ganz catheter, namely, indicator dilution, thermodilution, Fick's method, and continuous cardiac output monitoring are discussed. The article also describes the monitoring of right ventricle using Swan Ganz catheter equipped with a rapid response thermistor and electrodes for intracardiac ECG recording, and measurement of mixed venous oxygen saturation using Swan Ganz catheter incorporated with fiber-optic bundles. The controversies regarding the use of Swan Ganz catheter, including the evidence for and against is also dealt with.
Chapter
This article has no abstract.
Article
Methods of analysis used in the comparison of two methods of measurement are reviewed. The use of correlation, regression and the difference between means is criticized. A simple parametric approach is proposed based on analysis of variance and simple graphical methods.
Article
This year marks 40 years since the technique was designed of measuring and monitoring the basic haemodynamic parameters in humans by means of impedance cardiography (ICG), also known as "impedance plethysmography of the chest", "electrical bioimpedance of the chest" or "reocardiography". The method makes it possible to denote stroke volume and cardiac output. It also enables the factors to be assessed that influence the following: preload (measurement of thoracic fluid content), afterload (measurement of systemic vascular resistance), the systemic vascular resistance index, contractibility (measurement of the acceleration index), the velocity index, the pre-ejection period, left ventricular ejection time, systolic time ratio and heart rate. Advances in hardware and software, including digital signal tooling and new algorithms, have certainly improved the quality of the results obtained. The accuracy and repeatability of the results have been confirmed in comparative studies with results obtained through invasive methods and echocardiography. Not only are haemodynamic changes monitored by means of ICG in intensive care units, in operating theatres and at haemodialysis stations, but repeated measurements also provide haemodynamic information during the treatment of patients with hypertension and heart failure and pregnant women with cardiological problems and gestosis. A single ICG investigation makes a great contribution to the basic information available about the circulatory system, which is helpful in the initial evaluation of patients in a severe general condition (for example in the admission room), and also makes it possible to make a swift diagnosis of the cause of complaints such as dyspnoea and hypotonia. A particular application of ICG is the assessment of haemodynamic parameters during the programming of atrioventricular and CRT pacemakers. Besides these uses, ICG is a valuable investigative tool. It is defect-free and does not have pulmonary artery pressure monitoring limitations. Moreover, it is not as time-consuming as echocardiography and the examination can be performed by trained technicians or nurses. (Cardiol J 2007; 14: 115-126).